Skip to content

A randomized controlled study of Qinqiao Xiaodu granules in the treatment of influenza

A randomized controlled study of Qin-Qiao Xiao-Du Granule in the treatment of influenza

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004554
Enrollment
Unknown
Registered
2020-12-22
Start date
2020-12-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

Sponsors

Beijing institute of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Confirmed cases of influenza; 2. Patients aged >= 15 years and = 37.5 degrees C; 5. Patients who can accept examination, treatment and follow-up, and agree to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or puerperal women; 2. Patients with mental illness or others who are unable or unwilling to cooperate; 3. Those who have been participating in similar clinical trials in the past one month; 4. Patients with human acquired immunodeficiency syndrome; 5. Patients with influenza have been treated with antiviral drugs.

Design outcomes

Primary

MeasureTime frame
Complete antipyretic time;

Secondary

MeasureTime frame
Microecological changes of upper respiratory tract;Blood routine test;Incidence of common complications of influenza;Total duration of influenza;liver and kidney function;Influenza virus negative time;Drug combination;Differences of endogenous metabolites in serum;Influenza symptom remission score;

Countries

China

Contacts

Public ContactQingquan Liu

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

liuqingquan2003@126.com+86 10-52176677

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026